Clinical Trial

Rehabilitation With an Obturator in Maxillary Defects

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated August 15, 2024 (before its estimated September 20, 2024 completion). Its status may not reflect the trial's current state.
Summary
During the COVID-19 pandemic, there was a lot of reporting of COVID-19-associated mucormycosis cases. Managing this condition posed a new challenge to clinicians. Management includes therapeutic drugs and aggressive surgical debridement. Due to the unpredictability of disease prognosis and the possible recurrence of the disease, rehabilitation with delayed surgical obturators is beneficial for patients. Hence, the current study aimed to evaluate the impact of delayed surgical obturators on quality of life of COVID-19-associated mucormycosis patients post-maxillectomies
Protocol Amendment History 1 change
critical Trial status changed: Active, Not Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06515743
Lead Sponsor Menoufia University
Collaborators: Mansoura University
Conditions Mucormycosis
Enrollment 60 participants
Start Date 2024-02-04
Primary Completion 2024-09-20 (estimated)
Study Completion 2024-11-30 (estimated)
Updated on ClinicalTrials.gov 2024-08-15